Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-21

FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)

View source ↗

Summary

The FDA approved a supplemental application for Walgreens' CIMETIDINE 200 ACID REDUCER, indicating approval of changes to the approved generic cimetidine produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CIMETIDINE 200 ACID REDUCER (CIMETIDINE)

Snippet

SUPPL AP for CIMETIDINE 200 ACID REDUCER (CIMETIDINE)